OUTCOMES AFTER HEART TRANSPLANTATION FOR AL COMPARED TO ATTR CARDIAC AMYLOIDOSIS

Light-chain (AL) cardiac amyloidosis (CA) has a worse prognosis than transthyretin (ATTR) CA. In this single-center study, we compared post heart transplant (OHT) survival for AL and ATTR amyloidosis, hypothesizing that these differences would persist post-OHT. Thirty-nine patients with CA (AL, n=18...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transplant
Main Authors: Griffin, Jan M., Chiu, Leonard, Axsom, Kelly M., Bijou, Rachel, Clerkin, Kevin J., Colombo, Paolo, Cuomo, Margaret O., De Los Santos, Jeffeny, Fried, Justin A., Goldsmith, Jeff, Habal, Marlena, Haythe, Jennifer, Helmke, Stephen, Horn, Evelyn M., Latif, Farhana, Lee, Sun Hi, Lin, Edward F., Naka, Yoshifumi, Raikhelkar, Jayant, Restaino, Susan, Sayer, Gabriel T., Takayama, Hiroo, Takeda, Koji, Teruya, Sergio, Topkara, Veli, Tsai, Emily J., Uriel, Nir, Yuzefpolskaya, Melana, Farr, Maryjane A., Maurer, Mathew S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7744118/
https://ncbi.nlm.nih.gov/pubmed/32623785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ctr.14028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados